Hagay Sobol

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer.

Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer.

Journal: Nature communications

Published: August 15, 2024

Squamous Cell Carcinoma of the Lung With Microsatellite Instability in a Patient With Lynch Syndrome: A Case Report.

Squamous Cell Carcinoma of the Lung With Microsatellite Instability in a Patient With Lynch Syndrome: A Case Report.

Journal: JTO clinical and research reports

Published: May 31, 2023

Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.

Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 24, 2022

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Journal: American journal of human genetics

Published: June 15, 2021

Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer.

Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer.

Journal: The Prostate

Published: November 26, 2020

An overview of genetic predisposition to familial hematological malignancies.

An overview of genetic predisposition to familial hematological malignancies.

Journal: Bulletin du cancer

Published: November 02, 2020

Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.

Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.

Journal: Bulletin du cancer

Published: October 20, 2020

Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.

Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.

Journal: NPJ genomic medicine

Published: January 17, 2019

Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer.

Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer.

Journal: BMC medical genetics

Published: October 08, 2018

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Journal: Leukemia

Published: October 05, 2018

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.

Journal: Frontiers in oncology

Published: July 01, 2018

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Journal: Human mutation

Published: October 30, 2017

Showing 1-12 of 82

Last Updated: 09/26/2026